Pharmaceutical

Cellectis to focus on CAR-T cell therapies in 2023

Cellectis provided updates for the three CAR-T cell therapies trials, with the three trials recruiting across various cancer indications.

Aug 4, 2023 - 20:00
Cellectis to focus on CAR-T cell therapies in 2023
Cellectis provided updates for the three CAR-T cell therapies trials, with the three trials recruiting across various cancer indications.
Read the original article

Tags:

Previous Article

Accord gears up to commercialise Hipra’s Covid-19 vaccine in the UK

Next Article

Gilead reports 8.45% dip in net income for Q2 2023

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Thermo Fisher expands US manufacturing plant to support biologics

Thermo Fisher expands US manufacturing plant to support...

Oct 7, 2023

US DoD enlists VitriVax to develop one-shot vaccine for melioidosis

US DoD enlists VitriVax to develop one-shot vaccine for...

Jul 19, 2023

Actimed plans trials to treat muscle wasting syndrome in cancer patients

Actimed plans trials to treat muscle wasting syndrome i...

Jul 13, 2023